Ⓐ
PeptiBrief
Peptide medicine

Tirzepatide

Tirzepatide is a regulated peptide medicine with established evidence in defined indications.

Formula
C225H348N48O68
Molecular weight
4813.45 g/mol

Evidence confidence

Human
2/5
Some human clinical evidence
1 citation
Animal
Not yet assessed
Trust Engine review pending.
Mechanistic
Not yet assessed
Trust Engine review pending — see editorial links below.
Editorial evidence links exist, but this category has not yet completed Trust Engine assessment.
Safety
2/5
Partially characterised safety
1 citation

Claimed uses

Mechanisms

Safety notes

Adverse effects, contraindications and monitoring requirements depend on the approved formulation and indication.

Regulation
  • Approved prescription medicine in multiple jurisdictions, with brands and authorised indications varying by country and formulation.
  • Prescription or regulated medicine with jurisdiction-specific indications.

References

  1. Tirzepatide Once Weekly for the Treatment of Obesity · 2022
Last reviewed
12 July 2026
Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.